CITADEL ADVISORS LLC historic quarter change: USA Other Stocks, Sold out
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 8,173 positions, added to 6,540, reduced 6,603 and sold out of 7,821.
- Q4 2022: Stock LUMIRADX LTD; Country of operation —; Class SHS; Shares before 38,718.
- Q4 2022: Stock BRUUSH ORAL CARE INC; Country of operation —; Class COM; Shares before 38,326.
- Q4 2022: Stock SONOMA PHARMACEUTICALS INC; Country of operation —; Class COM NEW; Shares before 18,369.
- Q4 2022: Stock SQZ BIOTECHNOLOGIES CO; Country of operation —; Class COM; Shares before 16,891.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q4 2022 | LUMIRADX LTD
CUSIP G5709L109 | — | SHS | 38,718 | 0 | -38,718 | $39 | $0 | -$39 | 2023-02-14 |
|---|
| Q4 2022 | BRUUSH ORAL CARE INC
CUSIP 11750K203 | — | COM | 38,326 | 0 | -38,326 | $39 | $0 | -$39 | 2023-02-14 |
|---|
| Q4 2022 | SONOMA PHARMACEUTICALS INC
CUSIP 83558L204 | — | COM NEW | 18,369 | 0 | -18,369 | $39 | $0 | -$39 | 2023-02-14 |
|---|
| Q4 2022 | SQZ BIOTECHNOLOGIES CO
CUSIP 78472W104 | — | COM | 16,891 | 0 | -16,891 | $38 | $0 | -$38 | 2023-02-14 |
|---|
| Q4 2022 | EQONEX LIMITED
CUSIP Y2074E109 | — | SHS | 94,340 | 0 | -94,340 | $38 | $0 | -$38 | 2023-02-14 |
|---|
| Q4 2022 | HILL INTL INC
CUSIP 431466101 | — | COM | 11,499 | 0 | -11,499 | $38 | $0 | -$38 | 2023-02-14 |
|---|
| Q4 2022 | DURECT CORP
CUSIP 266605104 | — | COM | 63,544 | 0 | -63,544 | $37 | $0 | -$37 | 2023-02-14 |
|---|
| Q4 2022 | BARNES & NOBLE ED INC
CUSIP 06777U101 | — | COM | 15,073 | 0 | -15,073 | $36 | $0 | -$36 | 2023-02-14 |
|---|
| Q4 2022 | ITERIS INC NEW
CUSIP 46564T107 | — | COM | 12,236 | 0 | -12,236 | $36 | $0 | -$36 | 2023-02-14 |
|---|
| Q4 2022 | RECON TECHNOLOGY LTD
CUSIP G7415M124 | — | CL A SHS | 63,276 | 0 | -63,276 | $35 | $0 | -$35 | 2023-02-14 |
|---|
| Q4 2022 | NOVAN INC
CUSIP 66988N205 | — | COM NEW | 17,596 | 0 | -17,596 | $33 | $0 | -$33 | 2023-02-14 |
|---|
| Q4 2022 | VISLINK TECHNOLOGIES INC
CUSIP 92836Y300 | — | COM | 77,346 | 0 | -77,346 | $33 | $0 | -$33 | 2023-02-14 |
|---|
| Q4 2022 | PINEAPPLE ENERGY INC
CUSIP 72303P107 | — | COM | 37,821 | 0 | -37,821 | $33 | $0 | -$33 | 2023-02-14 |
|---|
| Q4 2022 | IBIO INC
CUSIP 451033203 | — | COM NEW | 191,939 | 0 | -191,939 | $33 | $0 | -$33 | 2023-02-14 |
|---|
| Q4 2022 | AUGMEDIX INC
CUSIP 05105P107 | — | COM | 23,090 | 0 | -23,090 | $33 | $0 | -$33 | 2023-02-14 |
|---|
| Q4 2022 | LOGICBIO THERAPEUTICS INC
CUSIP 54142F102 | — | COM | 115,925 | 0 | -115,925 | $32 | $0 | -$32 | 2023-02-14 |
|---|
| Q4 2022 | TANTECH HLDGS LTD
CUSIP G8675X123 | — | SHS NEW | 178,886 | 0 | -178,886 | $32 | $0 | -$32 | 2023-02-14 |
|---|
| Q4 2022 | TIAN RUIXIANG HLDGS LTD
CUSIP G8884K102 | — | CL A SHS | 48,806 | 0 | -48,806 | $30 | $0 | -$30 | 2023-02-14 |
|---|
| Q4 2022 | KALA PHARMACEUTICALS INC
CUSIP 483119103 | — | COM | 133,723 | 0 | -133,723 | $30 | $0 | -$30 | 2023-02-14 |
|---|
| Q4 2022 | CINEDIGM CORP
CUSIP 172406209 | — | COM NEW CL A | 73,244 | 0 | -73,244 | $29 | $0 | -$29 | 2023-02-14 |
|---|
| Q4 2022 | ADAMIS PHARMACEUTICALS CORP
CUSIP 00547W208 | — | COM NEW | 145,939 | 0 | -145,939 | $29 | $0 | -$29 | 2023-02-14 |
|---|
| Q4 2022 | OPGEN INC
CUSIP 68373L307 | — | COM | 100,773 | 0 | -100,773 | $29 | $0 | -$29 | 2023-02-14 |
|---|
| Q4 2022 | ELEVATE CREDIT INC
CUSIP 28621V101 | — | COM | 26,257 | 0 | -26,257 | $29 | $0 | -$29 | 2023-02-14 |
|---|
| Q4 2022 | EURO TECH HOLDINGS CO LTD
CUSIP G32030127 | — | SHS NEW | 21,965 | 0 | -21,965 | $27 | $0 | -$27 | 2023-02-14 |
|---|
| Q4 2022 | NOVO INTEGRATED SCIENCES INC
CUSIP 67011T201 | — | COM NEW | 23,381 | 0 | -23,381 | $25 | $0 | -$25 | 2023-02-14 |
|---|
| Q4 2022 | PHUNWARE INC
CUSIP 71948P100 | — | COM | 20,856 | 0 | -20,856 | $25 | $0 | -$25 | 2023-02-14 |
|---|
| Q4 2022 | EXPION360 INC
CUSIP 30218B100 | — | COM | 12,747 | 0 | -12,747 | $25 | $0 | -$25 | 2023-02-14 |
|---|
| Q4 2022 | TEAM INC
CUSIP 878155100 | — | COM | 23,698 | 0 | -23,698 | $25 | $0 | -$25 | 2023-02-14 |
|---|
| Q4 2022 | BLUE WATER VACCINES INC
CUSIP 09610B108 | — | COM | 14,274 | 0 | -14,274 | $24 | $0 | -$24 | 2023-02-14 |
|---|
| Q4 2022 | INDAPTUS THERAPEUTICS INC
CUSIP 45339J105 | — | COM | 10,895 | 0 | -10,895 | $24 | $0 | -$24 | 2023-02-14 |
|---|
| Q4 2022 | EYENOVIA INC
CUSIP 30234E104 | — | COM | 12,373 | 0 | -12,373 | $24 | $0 | -$24 | 2023-02-14 |
|---|
| Q4 2022 | APPHARVEST INC
CUSIP 03783T103 | — | COM | 11,683 | 0 | -11,683 | $23 | $0 | -$23 | 2023-02-14 |
|---|
| Q4 2022 | ACELRX PHARMACEUTICALS INC
CUSIP 00444T100 | — | COM | 108,916 | 0 | -108,916 | $23 | $0 | -$23 | 2023-02-14 |
|---|
| Q4 2022 | COCRYSTAL PHARMA INC
CUSIP 19188J300 | — | COM | 79,918 | 0 | -79,918 | $23 | $0 | -$23 | 2023-02-14 |
|---|
| Q4 2022 | ENDRA LIFE SCIENCES INC
CUSIP 29273B104 | — | COM | 75,957 | 0 | -75,957 | $23 | $0 | -$23 | 2023-02-14 |
|---|
| Q4 2022 | T2 BIOSYSTEMS INC
CUSIP 89853L104 | — | COM | 197,166 | 0 | -197,166 | $22 | $0 | -$22 | 2023-02-14 |
|---|
| Q4 2022 | KALERA PUBLIC LIMITED CO
CUSIP G52251108 | — | ORDINARY SHARES | 16,385 | 0 | -16,385 | $22 | $0 | -$22 | 2023-02-14 |
|---|
| Q4 2022 | INHIBIKASE THERAPEUTICS INC
CUSIP 45719W106 | — | COM | 24,114 | 0 | -24,114 | $22 | $0 | -$22 | 2023-02-14 |
|---|
| Q4 2022 | NETCAPITAL INC
CUSIP 64113L103 | — | COM | 11,050 | 0 | -11,050 | $21 | $0 | -$21 | 2023-02-14 |
|---|
| Q4 2022 | ONCOCYTE CORP
CUSIP 68235C107 | — | COM | 27,454 | 0 | -27,454 | $20 | $0 | -$20 | 2023-02-14 |
|---|
| Q4 2022 | ATHENEX INC
CUSIP 04685N103 | — | COM | 77,162 | 0 | -77,162 | $20 | $0 | -$20 | 2023-02-14 |
|---|
| Q4 2022 | BIOTRICITY INC
CUSIP 09074H104 | — | COM | 23,739 | 0 | -23,739 | $19 | $0 | -$19 | 2023-02-14 |
|---|
| Q4 2022 | HELIUS MED TECHNOLOGIES INC
CUSIP 42328V603 | — | COM CL A NEW | 69,563 | 0 | -69,563 | $19 | $0 | -$19 | 2023-02-14 |
|---|
| Q4 2022 | NOGIN INC
CUSIP 65528N105 | — | COM | 14,320 | 0 | -14,320 | $19 | $0 | -$19 | 2023-02-14 |
|---|
| Q4 2022 | ALTAMIRA THERAPEUTICS LTD
CUSIP G0360L100 | — | SHS | 64,820 | 0 | -64,820 | $19 | $0 | -$19 | 2023-02-14 |
|---|
| Q4 2022 | FREIGHT TECHNOLOGIES INC
CUSIP G51413105 | — | ORDINARY SHARES | 34,948 | 0 | -34,948 | $18 | $0 | -$18 | 2023-02-14 |
|---|
| Q4 2022 | NEXALIN TECHNOLOGY INC
CUSIP 65345B201 | United States | COM | 15,481 | 0 | -15,481 | $17 | $0 | -$17 | 2023-02-14 |
|---|
| Q4 2022 | CHECKPOINT THERAPEUTICS INC
CUSIP 162828107 | — | COM | 16,620 | 0 | -16,620 | $17 | $0 | -$17 | 2023-02-14 |
|---|
| Q4 2022 | FOXO TECHNOLOGIES INC
CUSIP 351471107 | — | COM CL A | 13,559 | 0 | -13,559 | $17 | $0 | -$17 | 2023-02-14 |
|---|
| Q4 2022 | ACTELIS NETWORKS INC
CUSIP 00503R102 | — | COM | 17,715 | 0 | -17,715 | $16 | $0 | -$16 | 2023-02-14 |
|---|
| Q4 2022 | GSE SYS INC
CUSIP 36227K106 | — | COM | 17,889 | 0 | -17,889 | $16 | $0 | -$16 | 2023-02-14 |
|---|
| Q4 2022 | JX LUXVENTURE LIMITED
CUSIP Y46002203 | — | COM NEW | 17,182 | 0 | -17,182 | $15 | $0 | -$15 | 2023-02-14 |
|---|
| Q4 2022 | MINERVA SURGICAL INC
CUSIP 60343F106 | — | COM | 18,532 | 0 | -18,532 | $15 | $0 | -$15 | 2023-02-14 |
|---|
| Q4 2022 | IVEDA SOLUTIONS INC
CUSIP 46583A204 | — | COM NEW | 24,010 | 0 | -24,010 | $15 | $0 | -$15 | 2023-02-14 |
|---|
| Q4 2022 | THE VERY GOOD FOOD CO INC
CUSIP 88340B109 | — | COM | 110,675 | 0 | -110,675 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | SYNLOGIC INC
CUSIP 87166L100 | — | COM | 14,998 | 0 | -14,998 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | ANGION BIOMEDICA CORP
CUSIP 03476J107 | — | COM | 14,675 | 0 | -14,675 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | BIOSIG TECHNOLOGIES INC
CUSIP 09073N201 | — | COM NEW | 21,776 | 0 | -21,776 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | TITAN PHARMACEUTICALS INC DE
CUSIP 888314606 | — | COM NEW | 13,076 | 0 | -13,076 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | TONIX PHARMACEUTICALS HLDG C
CUSIP 890260862 | — | COM NEW | 26,159 | 0 | -26,159 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | SHARPS TECHNOLOGY INC
CUSIP 82003F101 | — | COMMON STOCK | 12,253 | 0 | -12,253 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | EDIBLE GARDEN AG INC
CUSIP 28059P105 | — | COM | 22,634 | 0 | -22,634 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | UNIQUE FABRICATING INC
CUSIP 90915J103 | — | COM | 28,341 | 0 | -28,341 | $14 | $0 | -$14 | 2023-02-14 |
|---|
| Q4 2022 | BROOKLYN IMMUNOTHERAPEUTICS
CUSIP 114082100 | — | COM | 50,572 | 0 | -50,572 | $13 | $0 | -$13 | 2023-02-14 |
|---|
| Q4 2022 | VYANT BIO INC
CUSIP 92942V109 | — | COM | 21,558 | 0 | -21,558 | $12 | $0 | -$12 | 2023-02-14 |
|---|
| Q4 2022 | NEW CONCEPT ENERGY INC
CUSIP 643611106 | United States | COM | 11,072 | 0 | -11,072 | $12 | $0 | -$12 | 2023-02-14 |
|---|
| Q4 2022 | KIROMIC BIOPHARMA INC
CUSIP 497634105 | — | COM | 39,865 | 0 | -39,865 | $12 | $0 | -$12 | 2023-02-14 |
|---|
| Q4 2022 | NANTHEALTH INC
CUSIP 630104107 | — | COM | 47,954 | 0 | -47,954 | $12 | $0 | -$12 | 2023-02-14 |
|---|
| Q4 2022 | ABVC BIOPHARMA INC
CUSIP 00091F106 | — | COM | 12,612 | 0 | -12,612 | $11 | $0 | -$11 | 2023-02-14 |
|---|
| Q4 2022 | BIOMX INC
CUSIP 09090D103 | — | COM | 31,945 | 0 | -31,945 | $11 | $0 | -$11 | 2023-02-14 |
|---|
| Q4 2022 | PAINREFORM LTD
CUSIP M77798102 | — | SHS | 15,239 | 0 | -15,239 | $11 | $0 | -$11 | 2023-02-14 |
|---|
| Q4 2022 | ACASTI PHARMA INC
CUSIP 00430K873 | — | CL A | 17,826 | 0 | -17,826 | $10 | $0 | -$10 | 2023-02-14 |
|---|
| Q4 2022 | DOMA HOLDINGS INC
CUSIP 25703A104 | — | COMMON STOCK | 23,385 | 0 | -23,385 | $10 | $0 | -$10 | 2023-02-14 |
|---|
| Q4 2022 | ELOXX PHARMACEUTICALS INC
CUSIP 29014R103 | — | COM | 58,622 | 0 | -58,622 | $10 | $0 | -$10 | 2023-02-14 |
|---|
| Q4 2022 | ELYS GAME TECHNOLOGY CORP
CUSIP 290734102 | — | COM | 21,947 | 0 | -21,947 | $10 | $0 | -$10 | 2023-02-14 |
|---|
| Q4 2022 | CEMTREX INC
CUSIP 15130G600 | — | COM NEW | 48,217 | 0 | -48,217 | $10 | $0 | -$10 | 2023-02-14 |
|---|
| Q4 2022 | CYCLERION THERAPEUTICS INC
CUSIP 23255M105 | — | COM | 10,651 | 0 | -10,651 | $9 | $0 | -$9 | 2023-02-14 |
|---|
| Q4 2022 | GROM SOCIAL ENTERPRISES INC
CUSIP 39878L308 | — | COM NEW | 27,856 | 0 | -27,856 | $9 | $0 | -$9 | 2023-02-14 |
|---|
| Q4 2022 | QUANERGY SYSTEMS INC
CUSIP 74764U104 | — | COM | 45,441 | 0 | -45,441 | $9 | $0 | -$9 | 2023-02-14 |
|---|
| Q4 2022 | NEUBASE THERAPEUTICS INC
CUSIP 64132K102 | — | COM | 22,799 | 0 | -22,799 | $9 | $0 | -$9 | 2023-02-14 |
|---|
| Q4 2022 | ALPINE 4 HOLDINGS INC
CUSIP 02083E105 | — | CL A | 16,526 | 0 | -16,526 | $9 | $0 | -$9 | 2023-02-14 |
|---|
| Q4 2022 | ONCOSEC MED INC
CUSIP 68234L306 | — | COM | 15,640 | 0 | -15,640 | $8 | $0 | -$8 | 2023-02-14 |
|---|
| Q4 2022 | NISUN INTL ENT DVPMT GP CO L
CUSIP G6593L106 | — | COM CL A | 14,169 | 0 | -14,169 | $7 | $0 | -$7 | 2023-02-14 |
|---|
| Q4 2022 | BIT BROTHER LIMITED
CUSIP G1144D109 | — | CLASS A ORD | 57,578 | 0 | -57,578 | $7 | $0 | -$7 | 2023-02-14 |
|---|
| Q4 2022 | SEQLL INC
CUSIP 81734C106 | — | COM | 10,820 | 0 | -10,820 | $7 | $0 | -$7 | 2023-02-14 |
|---|
| Q4 2022 | PLUS THERAPEUTICS INC
CUSIP 72941H400 | — | COM NEW | 16,772 | 0 | -16,772 | $7 | $0 | -$7 | 2023-02-14 |
|---|
| Q4 2022 | INDIA GLOBALIZATION CAP INC
CUSIP 45408X308 | United States | COM NEW | 15,583 | 0 | -15,583 | $7 | $0 | -$7 | 2023-02-14 |
|---|
| Q4 2022 | MAWSON INFRASTRUCTURE GROUP
CUSIP 57778N208 | — | COM NEW | 13,664 | 0 | -13,664 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | 9 METERS BIOPHARMA INC
CUSIP 654405109 | — | COM | 27,808 | 0 | -27,808 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | NUZEE INC
CUSIP 67073S208 | — | COM NEW | 18,996 | 0 | -18,996 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | REVELATION BIOSCIENCES INC
CUSIP 76135L101 | — | COM | 22,547 | 0 | -22,547 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | GALMED PHARMACEUTICALS LTD
CUSIP M47238106 | — | SHS | 18,628 | 0 | -18,628 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | IMV INC
CUSIP 44974L103 | — | COM | 10,487 | 0 | -10,487 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | AGEX THERAPEUTICS INC
CUSIP 00848H108 | — | COM | 10,029 | 0 | -10,029 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | EZGO TECHNOLOGIES LTD
CUSIP G5279F102 | — | SHS | 14,104 | 0 | -14,104 | $6 | $0 | -$6 | 2023-02-14 |
|---|
| Q4 2022 | CARLOTZ INC
CUSIP 142552108 | — | COM CL A | 16,995 | 0 | -16,995 | $5 | $0 | -$5 | 2023-02-14 |
|---|
| Q4 2022 | CAMBER ENERGY INC
CUSIP 13200M508 | — | COM | 24,748 | 0 | -24,748 | $5 | $0 | -$5 | 2023-02-14 |
|---|
| Q4 2022 | DIRTT ENVIRONMENTAL SOLUTION
CUSIP 25490H106 | — | COM | 10,094 | 0 | -10,094 | $4 | $0 | -$4 | 2023-02-14 |
|---|
| Q4 2022 | LOTTERY COM INC
CUSIP 54570M108 | — | COM | 17,034 | 0 | -17,034 | $4 | $0 | -$4 | 2023-02-14 |
|---|
| Q4 2022 | AMESITE INC
CUSIP 031094105 | — | COM | 16,719 | 0 | -16,719 | $4 | $0 | -$4 | 2023-02-14 |
|---|